Beyond the existing FLIPI parameters, the FLIPI2 study explored the inclusion of β2-microglobulin (B2M), a protein associated with lymphocyte activity and a potential marker of tumor burden and cell turnover. This evidence concerns the gene B2M and neoplasm.